10-K Decoder · All companies

Vertex Pharmaceuticals Incorporated

VRTX · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$12.0B$11.0B+8.9%
Operating income$4.17B−$233M
Net income$3.95B−$536M

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 3, 2026

$Q3 2026Year earlierChange
Revenue$3.44B$3.08B+11.8%
Operating income$713M$1.19B−39.9%
Net income$654M$1.08B−39.6%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Vertex's revenue in FY2025?
$12.0B in FY2025 (Fiscal year ended Dec 31, 2025), +8.9% vs $11.0B a year earlier, per its 10-K filed Feb 2026.
Was Vertex profitable in FY2025?
Yes: net income was $3.95B and operating income $4.17B in FY2025.
What was Vertex's revenue in Q3 2026?
$3.44B (+11.8% vs a year earlier), per its Form 10-Q filed Nov 3, 2026.